Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

NCT01369069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1151

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke
Diabetes
Hyperglycemia

Interventions

DRUG: IV insulin to maintain target glucose concentration of 80-130 mg/dL
DRUG: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL

Sponsor

University of Virginia

Collaborators

[object Object]
[object Object]
[object Object]